These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15816372)

  • 1. A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex.
    Cignarelli M; Picca G; Campo M; Margaglione M; Marino A; Logoluso F; Giorgino F
    J Endocrinol Invest; 2005 Jan; 28(1):54-60. PubMed ID: 15816372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotane and Carney Complex: ten years follow-up of a low-dose mitotane regimen inducing a sustained correction of hypercortisolism.
    Campo MR; Lamacchia O; Farese A; Conserva A; Picca G; Grilli G; Cignarelli M
    Hormones (Athens); 2015; 14(2):300-4. PubMed ID: 25402388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy.
    Sarlis NJ; Chrousos GP; Doppman JL; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1274-8. PubMed ID: 9100606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
    Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT
    Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary pigmented nodular adrenocortical disease associated with Carney complex: case report and literature review.
    Gonçalves FT; Feibelmann TC; Mendes CM; Fernandes ML; Miranda GH; Gouvêa AP; Jorge PT
    Sao Paulo Med J; 2006 Nov; 124(6):336-9. PubMed ID: 17322955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
    Alexandraki KI; Kaltsas GA; le Roux CW; Fassnacht M; Ajodha S; Christ-Crain M; Akker SA; Drake WM; Edwards R; Allolio B; Grossman AB
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):305-11. PubMed ID: 19473175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.
    Stratakis CA; Carney JA; Kirschner LS; Willenberg HS; Brauer S; Ehrhart-Bornstein M; Bornstein SR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1122-8. PubMed ID: 10084605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary pigmented nodular adrenocortical disease as cause of Cushing's syndrome associated with Carney complex].
    Dumić M; Janjanin N; Uroić AS; Ille J; Skegro M; Kusec V; Marjanac I; Matić T; Jelasić D
    Lijec Vjesn; 2006; 128(9-10):268-73. PubMed ID: 17128664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.
    Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M
    Endocr Relat Cancer; 2008 Dec; 15(4):1043-53. PubMed ID: 18824557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
    Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M
    Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma].
    Lecka A; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary pigmented nodular adrenocortical dysplasia. A rare cause of Cushing's syndrome].
    Anding K; Köhler G; Böhm N; Petersen KG; Schollmeyer P; Neumann HP
    Dtsch Med Wochenschr; 1996 Oct; 121(43):1321-4. PubMed ID: 8964212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?
    Gunther DF; Bourdeau I; Matyakhina L; Cassarino D; Kleiner DE; Griffin K; Courkoutsakis N; Abu-Asab M; Tsokos M; Keil M; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3173-82. PubMed ID: 15240590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.
    Kerkhofs TM; Baudin E; Terzolo M; Allolio B; Chadarevian R; Mueller HH; Skogseid B; Leboulleux S; Mantero F; Haak HR; Fassnacht M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4759-67. PubMed ID: 24057287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.